U.S. market Closed. Opens in 2 days 4 hours 18 minutes

BVS | Bioventus Inc. Stock Overview

(Stock Exchange: NASDAQ)
Day's Range 11.30 - 11.89
52 Week Range 3.77 - 14.38
Beta 0.87
Implied Volatility 118.06%
IV Rank 34.81%
Day's Volume 287,878
Average Volume 485,690
Shares Outstanding 65,367,800
Market Cap 765,456,938
Sector Healthcare
Industry Medical - Devices
IPO Date 2021-02-11
Valuation
Profitability
Growth
Health
P/E Ratio -19.20
Forward P/E Ratio N/A
EPS -0.61
1YR Price Target N/A
Dividend Yield N/A
Dividend Per Share N/A
Dividend ExDate N/A
Dividend PayDate N/A
Employees 1,030
Country USA
Website BVS
Bioventus Inc. a medical device company, focuses on developing and commercializing clinical treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral nerve stimulation products. Its surgical solutions comprise bone graft substitutes to fuse and grow bones, enhance results following spinal and other orthopedic surgeries; and ultrasonic medical devices for the use in precise bone sculpting, remove tumors, and tissue debridement. The company's restorative therapies include an ultrasonic bone healing system for fracture care; skin allografts; and products that are used to support healing of chronic wounds, as well as advanced rehabilitation devices designed to help patients regain leg or hand function. It serves physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine, and neurosurgery in the physician's office or clinic, ambulatory surgical centers, or in the hospital setting. The company was founded in 2011 and is headquartered in Durham, North Carolina.
BVS's peers: ARAY, TIVC, TLIS, BJDX, HSCS, NUWE, BBLG, NAOV, VVOS, RPID, CERS, OWLT, RBOT
*Chart delayed
Analyzing fundamentals for BVS we got that it has weak fundamentals where Valuation is considered to be overvalued, Profitability is unacceptably poor, Growth is bad and Health is frighteningly weak. For more detailed analysis please see BVS Fundamentals page.

Watching at BVS technicals we can see that long-term trend is bullish, the same as bullish middle-term trend, but short-term trend is bearish. More technicals details can be found on BVS Technicals page.
An error has occurred. This application may no longer respond until reloaded. Reload 🗙